1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN
125.30 5.65 (4.72%)
2.3M

XNAS 29 Jul, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Repligen Corp. is on 30 Jul 2025 for the purpose of Repligen Corp Second Quarter Earnings Results for 2025 See details

Detailed Stock Analysis for Repligen Corp. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in